StockData
Alnylam Pharmaceuticals, Inc. logo

Alnylam Pharmaceuticals, Inc. (ALNY) stock

ALNYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 10/3047% below fair value
$149.40−7.10 (-4.54%)

Close on Nov 18, 2026Market cap $20.01BP/E 7.8Yield –

Alnylam Pharmaceuticals enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Alnylam Pharmaceuticals's enterprise value was $18.07B on Nov 11, 2026, against $56.74B a year earlier. Over the last 5 years it ranged from $12.98B to $56.87B, with a median of $24.89B.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$18.07B-63.6%
2025Dec 31, 2025$49.68B+80.4%
2024Dec 31, 2024$27.55B+27.4%
2023Dec 29, 2023$21.62B-19.9%
2022Dec 30, 2022$26.99B+49.9%
2021Dec 31, 2021$18.01B+35.2%
2020Dec 31, 2020$13.32B+20.0%
2019Dec 31, 2019$11.10B+80.8%
2018Dec 31, 2018$6.14B-43.1%
2017Dec 29, 2017$10.79B+329.5%
2016Dec 30, 2016$2.51B-64.1%
2015Dec 31, 2015$7.00B+2.2%
2014Dec 31, 2014$6.85B+76.8%
2013Dec 31, 2013$3.87B+432.2%
2012Dec 31, 2012$727.58M+316.0%
2011Dec 30, 2011$174.89M-5.1%
2010Dec 31, 2010$184.33M–

More Alnylam Pharmaceuticals figures

See a number that looks wrong?